17-59893307-G-C
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The ENST00000225577.9(RPS6KB1):āc.123G>Cā(p.Glu41Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000658 in 1,609,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000225577.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPS6KB1 | NM_003161.4 | c.123G>C | p.Glu41Asp | missense_variant | 1/15 | ENST00000225577.9 | NP_003152.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPS6KB1 | ENST00000225577.9 | c.123G>C | p.Glu41Asp | missense_variant | 1/15 | 1 | NM_003161.4 | ENSP00000225577 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000590 AC: 14AN: 237342Hom.: 0 AF XY: 0.0000464 AC XY: 6AN XY: 129420
GnomAD4 exome AF: 0.0000672 AC: 98AN: 1457698Hom.: 0 Cov.: 31 AF XY: 0.0000676 AC XY: 49AN XY: 724770
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | The c.123G>C (p.E41D) alteration is located in exon 1 (coding exon 1) of the RPS6KB1 gene. This alteration results from a G to C substitution at nucleotide position 123, causing the glutamic acid (E) at amino acid position 41 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at